🏅 FDA Orphan Designation
BabyBIG
Botulism immune globulin
Manufacturer: California Department of Public Health
Indicated for:
Infant botulismOrphan
FDA-Approved Indications (1)
Infant botulismOrphan Designation
Indicated for treatment of infant botulism caused by type A or type B Clostridium botulinum.
Indications & Usage
1 INDICATIONS AND USAGE BabyBIG ® , Botulism Immune Globulin Intravenous (Human), is indicated for the treatment of infant botulism caused by toxin type A or B in patients below one year of age. BabyBIG is an immune globulin intravenous (human) indicated for: Treatment of infant botulism caused by toxin types A or B in patients below one year of age ( 1 ).
💙 Support Programs
View all →BabyBIG
California Department of Public Health
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.